[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 Global Dihydroartemisinin Industry Report - History, Present and Future

November 2018 | 149 pages | ID: 20B2715E2F0EN
Prof Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global market size of Dihydroartemisinin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Dihydroartemisinin as well as some small players. The compnaies include:

Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource, Botanical Extracts EPZ Lt et al.

The information for each competitor includes:
  • Company Profile
  • Main Business Information
  • SWOT Analysis
  • Sales, Revenue, Price and Gross Margin
  • Market Share
We also can offer customized report to fulfill special requirements of our clients.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Dihydroartemisinin Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Dihydroartemisinin by Region
8.2 Import of Dihydroartemisinin by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT DIHYDROARTEMISININ MARKET IN NORTH AMERICA (2013-2018)

9.1 Dihydroartemisinin Supply
9.2 Dihydroartemisinin Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT DIHYDROARTEMISININ MARKET IN SOUTH AMERICA (2013-2018)

10.1 Dihydroartemisinin Supply
10.2 Dihydroartemisinin Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT DIHYDROARTEMISININ MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Dihydroartemisinin Supply
11.2 Dihydroartemisinin Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT DIHYDROARTEMISININ MARKET IN EUROPE (2013-2018)

12.1 Dihydroartemisinin Supply
12.2 Dihydroartemisinin Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT DIHYDROARTEMISININ MARKET IN MEA (2013-2018)

13.1 Dihydroartemisinin Supply
13.2 Dihydroartemisinin Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL DIHYDROARTEMISININ MARKET (2013-2018)

14.1 Dihydroartemisinin Supply
14.2 Dihydroartemisinin Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL DIHYDROARTEMISININ MARKET FORECAST (2019-2023)

15.1 Dihydroartemisinin Supply Forecast
15.2 Dihydroartemisinin Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(SANOFI, KPC PHARMACEUTICALS, GUANGXI XIANCAOTANG PHARMACEUTICAL, GUILIN PHARMACEUTICAL, KERUI NANHAI PHARMACEUTICAL, SHANGHAI NATURAL BIO-ENGINEERING CO, NOVANAT BIORESOURCE, BOTANICAL EXTRACTS EPZ LT ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Dihydroartemisinin Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Dihydroartemisinin Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Dihydroartemisinin Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Dihydroartemisinin Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Dihydroartemisinin Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Dihydroartemisinin Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Dihydroartemisinin Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2013-2018)

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Dihydroartemisinin Report
Table Primary Sources of Dihydroartemisinin Report
Table Secondary Sources of Dihydroartemisinin Report
Table Major Assumptions of Dihydroartemisinin Report
Figure Dihydroartemisinin Picture
Table Dihydroartemisinin Classification
Table Dihydroartemisinin Applications List
Table Drivers of Dihydroartemisinin Market
Table Restraints of Dihydroartemisinin Market
Table Opportunities of Dihydroartemisinin Market
Table Threats of Dihydroartemisinin Market
Table Key Raw Material of Dihydroartemisinin and Its Suppliers
Table Key Technologies of Dihydroartemisinin
Table Cost Structure of Dihydroartemisinin
Table Market Channel of Dihydroartemisinin
Table Dihydroartemisinin Application and Key End Users List
Table Latest News of Dihydroartemisinin Industry
Table Recently Merger and Acquisition List of Dihydroartemisinin Industry
Table Recently Planned/Future Project List of Dihydroartemisinin Industry
Table Policy Dynamics Update of Dihydroartemisinin Industry
Table 2013-2023 Export of Dihydroartemisinin by Region
Table 2013-2023 Import of Dihydroartemisinin by Region
Table 2013-2023 Balance of Trade of Dihydroartemisinin
Figure 2013 2018 and 2023 Global Trade Map of Dihydroartemisinin
Table 2013-2018 North America Supply of Dihydroartemisinin
Figure 2013-2018 North America Dihydroartemisinin Supply and GAGR
Table 2013-2018 North America Dihydroartemisinin Downstream Demand List
Figure 2013-2018 North America Dihydroartemisinin Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Dihydroartemisinin Demand by Type
Figure 2013-2018 North America Dihydroartemisinin Price
Table 2013-2018 Key Countries Supply of Dihydroartemisinin in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Dihydroartemisinin in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Dihydroartemisinin
Figure 2013-2018 South America Dihydroartemisinin Supply and GAGR
Table 2013-2018 South America Dihydroartemisinin Downstream Demand List
Figure 2013-2018 South America Dihydroartemisinin Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Dihydroartemisinin Demand by Type
Figure 2013-2018 South America Dihydroartemisinin Price
Table 2013-2018 Key Countries Supply of Dihydroartemisinin in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Dihydroartemisinin in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Dihydroartemisinin
Figure 2013-2018 Asia & Pacific Dihydroartemisinin Supply and GAGR
Table 2013-2018 Asia & Pacific Dihydroartemisinin Downstream Demand List
Figure 2013-2018 Asia & Pacific Dihydroartemisinin Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Dihydroartemisinin Demand by Type
Figure 2013-2018 Asia & Pacific Dihydroartemisinin Price
Table 2013-2018 Key Countries Supply of Dihydroartemisinin in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Dihydroartemisinin in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Dihydroartemisinin
Figure 2013-2018 Europe Dihydroartemisinin Supply and GAGR
Table 2013-2018 Europe Dihydroartemisinin Downstream Demand List
Figure 2013-2018 Europe Dihydroartemisinin Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Dihydroartemisinin Demand by Type
Figure 2013-2018 Europe Dihydroartemisinin Price
Table 2013-2018 Key Countries Supply of Dihydroartemisinin in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Dihydroartemisinin in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Dihydroartemisinin
Figure 2013-2018 MEA Dihydroartemisinin Supply and GAGR
Table 2013-2018 MEA Dihydroartemisinin Downstream Demand List
Figure 2013-2018 MEA Dihydroartemisinin Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Dihydroartemisinin Demand by Type
Figure 2013-2018 MEA Dihydroartemisinin Price
Table 2013-2018 Key Countries Supply of Dihydroartemisinin in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Dihydroartemisinin in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Dihydroartemisinin by Region
Figure 2013-2018 Global Supply and CAGR of Dihydroartemisinin by Region
Table 2013-2018 Global Dihydroartemisinin Downstream Demand List by Region
Figure 2013-2018 Global Dihydroartemisinin Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Dihydroartemisinin Type-wise Demand by Region
Figure 2013-2018 Global Dihydroartemisinin Price
Table Main Business and Dihydroartemisinin Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company A Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company B Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company C Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company D Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company E Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company F Dihydroartemisinin Market Share
Table Main Business and Dihydroartemisinin Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Dihydroartemisinin Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Dihydroartemisinin Sales Revenue and Growth Rate
Figure 2013-2018 Company G Dihydroartemisinin Market Share


More Publications